Botox Clinical Trials Botox RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines
Condition:   Moderate to Severe Glabellar Lines Interventions:   Biological: YY001;   Biological: OnabotulinumtoxinA;   Biological: Placebo Sponsor:   Chongqing Claruvis Pharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2023 Category: Research Source Type: clinical trials